Trials / Completed
CompletedNCT00236236
The HF-HRV Registry
CONTAK RENEWAL® Heart Failure Heart Rate Variability Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,400 (planned)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Registry will evaluate how HRV Monitor diagnostics change after cardiac resynchronization therapy in patients with heart failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cardiac Resynchronization Therapy |
Timeline
- Start date
- 2003-02-01
- Completion
- 2005-05-01
- First posted
- 2005-10-12
- Last updated
- 2006-11-14
Source: ClinicalTrials.gov record NCT00236236. Inclusion in this directory is not an endorsement.